This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Adherence With Iron Sprinkles Among High-Risk Infants

This study has been completed.
Information provided by:
Centers for Disease Control and Prevention Identifier:
First received: August 25, 2005
Last updated: February 2, 2016
Last verified: September 2007
Compared with iron drops, iron sprinkles supplied for 3 months to high-risk children beginning at age 5-7 months will increase adherence and reduce the rates of anemia and iron deficiency.

Condition Intervention Phase
Anemia Iron Deficiency Drug: Ferrous sulphate drops with vitamins A, D, and C Drug: Ferrous fumarate sprinkles with vitamins and minerals Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Adherence With Iron Sprinkles Among High-Risk Infants

Resource links provided by NLM:

Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • full adherence, use of iron supplements 6-7 days/week for 3 months

Secondary Outcome Measures:
  • iron deficiency at 9 months of age
  • anemia at 9 months of age

Enrollment: 128
Study Start Date: March 2005
Study Completion Date: December 2005
Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
Detailed Description:

Iron deficiency is the most common known nutrient deficiency and cause of anemia in childhood. It is associated with numerous adverse health effects, particularly delayed mental and motor development, that may be irreversible. Despite advances of iron nutrition, the prevalence of iron deficiency remains high among low-income infants and toddlers. Previous studies suggest adherence with iron containing drops is low. Adherence to iron sprinkles among children as tested in studies in less developed countries appears high.

Comparison: Children randomized to ferrous sulfate drops will be compared with children randomized to ferrous fumarate sprinkles.


Ages Eligible for Study:   5 Months to 7 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy infants
  • Age 5-7 months
  • Presenting for 6 months well-child care
  • Caregiver speaks English or Spanish

Exclusion Criteria:

  • Pre-existing medical conditions with potential relation to iron deficiency or anemia (e.g., hemoglobinopathies, gastrointestinal disorders resulting in malabsorption, chronic renal disease, gestational age at birth of less than 36 weeks, and HIV infection)
  • Inability to speak English or Spanish
  • Use of vitamin or iron supplements in the previous three months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00136266

United States, Massachusetts
Whittier Street Health Center
Boston, Massachusetts, United States, 02108
Boston Medical Center Pediatric Primary Care Clinic
Boston, Massachusetts, United States, 02118
Sponsors and Collaborators
Centers for Disease Control and Prevention
Principal Investigator: Paul L. Geltman, MD, MPH Boston University
  More Information

Publications: Identifier: NCT00136266     History of Changes
Other Study ID Numbers: CDC-NCCDPHP-MM-0835-O5/05
Study First Received: August 25, 2005
Last Updated: February 2, 2016

Keywords provided by Centers for Disease Control and Prevention:
Iron deficiency

Additional relevant MeSH terms:
Anemia, Iron-Deficiency
Anemia, Hypochromic
Hematologic Diseases
Iron Metabolism Disorders
Metabolic Diseases
Vitamin A
Vitamin D
Ferrous fumarate
Growth Substances
Physiological Effects of Drugs
Trace Elements
Bone Density Conservation Agents processed this record on August 18, 2017